PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,042,000 | -81.8% | 212,698 | -75.3% | 0.01% | -80.8% |
| Q3 2016 | $5,739,000 | -3.9% | 860,464 | -30.3% | 0.05% | -17.5% |
| Q2 2016 | $5,973,000 | -9.3% | 1,234,095 | -8.6% | 0.06% | -8.7% |
| Q1 2016 | $6,587,000 | -23.2% | 1,349,719 | +36.6% | 0.07% | -2.8% |
| Q4 2015 | $8,578,000 | -40.4% | 988,299 | 0.0% | 0.07% | -46.6% |
| Q3 2015 | $14,400,000 | -12.6% | 988,299 | 0.0% | 0.13% | -8.3% |
| Q2 2015 | $16,475,000 | +88.2% | 988,299 | +147.1% | 0.14% | +98.6% |
| Q1 2015 | $8,752,000 | +1.0% | 400,000 | 0.0% | 0.07% | -17.0% |
| Q4 2014 | $8,668,000 | +26.1% | 400,000 | 0.0% | 0.09% | +1.1% |
| Q3 2014 | $6,876,000 | – | 400,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |